Clinical Data

Close-up of human eye
Biotech

Opus sets sights on FDA talks after posting gene therapy data

Opus Genetics shared data on its gene therapy in kids with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps.
Nick Paul Taylor Sep 30, 2025 9:15am
Stock decreasing graphic

Applied Tx's stock drops on non-update for rare disease asset

Sep 29, 2025 10:57am
RSV

Enanta sees RSV drug fail phase 2b but finds positives

Sep 29, 2025 8:05am
step up climb ladder sky hang on rung

BMS reports phase 3 win in multiple myeloma

Sep 23, 2025 8:20am
An arrow incrementally going up stairs before pointing straight up Blue background

Roche reports phase 3 breast cancer victory for oral SERD

Sep 22, 2025 7:25am
obesity overweight weight loss weigh

QL Biopharm links monthly GLP-1 to incumbent-rivaling efficacy

Sep 18, 2025 7:20am